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Background: Growth differentiation factor 6 (GDF6) has been reported to be a novel disease gene for age-related
macular degeneration (AMD) in Caucasians. This study aimed to investigate whether rs6982567 was associated with
neovascular AMD (nAMD) or polypoidal choroidal vasculopathy (PCV) in a Han Chinese cohort.
Methods: A total of 612 participants (251 PCV patients, 157 nAMD patients and 204 controls) were included in this
study. The SNaPshot system was used to genotype the rs6982567. PLINK software was used to evaluate the genotypes
and allele frequencies of patients and controls.
Results: The allele frequencies of rs6982567 were not significantly associated with nAMD, PCV or PCV and nAMD
combined. Subjects with the TT genotype had a 2.42-fold greater risk of PCV (95% confidence interval, 1.07-5.43,
p = 0.0290) than subjects with CC genotype. A recessive model of rs6982567 was statistically significantly associated
with PCV (odds ratio, 2.29; 95% confidence interval, 1.04-5.05; p = 0.0351). However, the association did not withstand
stringent Bonferroni correction. There were no significant differences in genotype distributions or models in nAMD.
Conclusions: There was a possible weak association between the rs6982567 near GDF6 and PCV in this replication
study with an independent Han Chinese cohort. A complete survey of the GDF6 locus with a larger sample size is
needed in future studies.
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Polymorphisms, Growth differentiation factor 6Background
Age-related macular degeneration (AMD) is a major cause
of irreversible blindness around the world [1]. Neovascular
AMD (nAMD) is one process of advanced AMD, charac-
terised by typical choroidal neovascularisation (CNV) that
can cause severe vision loss [2]. Polypoidal choroidal
vasculopathy (PCV) is an exudative maculopathy marked
by branching networks of inner choroidal vessels and a
nodular appearance on stereoscopic view with indocyanine
green angiography (ICGA) [3]. Emerging evidence has
shown that PCV is more common in Asians than in
Caucasians [4,5], and it has been recognised as a special* Correspondence: wenfeng208@foxmail.com
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unless otherwise stated.type of CNV [6,7]. However, the prevalence, clinical
features and treatment guidelines are somewhat differ-
ent. Although nAMD and PCV share some common
genetic determinants, such as the complement factor H
gene (CFH) and the high temperature requirement factor
A1 (HTRA1) gene [8,9], they are not the same. For ex-
ample, superkiller viralicidic activity 2-like (SKIV2 L),
in the entire C2 (complement component 2)-CFB (com-
plement factor B)-RDBP (RD RNA-binding protein)-
SKIV2 L region, is associated with nAMD but not with
PCV [10]. The rs5882 near cholesteryl ester transfer
protein (CETP) is significantly associated with PCV
but not with nAMD [11].
Growth differentiation factor 6 (GDF6) is a member of
transforming growth factor-β (TGF-β) superfamily. It canhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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development [12,13] and can regulate ectoderm patterning
[14]. It also plays a role in tissue modelling and remodel-
ling [15]. Recently, a study in a Caucasian cohort identified
that a single nucleotide polymorphism (SNP) rs6982567
near GDF6 was associated with AMD [16]. Given that early
AMD, advanced AMD, and PCV were not distinguished in
this study, and no research about this SNP has been under-
taken in Chinese populations, we conducted this study to
determine whether rs6982567 was associated with nAMD
and PCV in a Han Chinese population.
Methods
The study followed the tenets of the Declaration of
Helsinki, and the protocol was approved by the institu-
tional review board at the Zhongshan Ophthalmic Center
of Sun Yat-sen University (lot number: KYNL015). All of
the participants signed written informed consent forms
after explanation of the purpose and process of the study.
Study participants
All of the participants were enrolled from Zhongshan
Ophthalmic Center from November 2008 to July 2011.
They were all Chinese and were not related to each other.
All of the PCV and nAMD patients were newly diagnosed
and received no prior treatment. They all underwent bilat-
eral ocular examinations, including best-corrected visual
acuity, slit-lamp biomicroscopy, direct ophthalmoscopy,
colour fundus photographs, fundus fluorescein angiography
(FFA), and ICGA. Diagnosis was made according to the
worse eye. PCV was defined as characteristic polypoidal
choroidal vascular dilations with branching inner choroidal
vascular networks within the first 5 min after indocyanine
green injection on ICGA. Typical CNV, observed on both
FFA and ICGA, was diagnosed as nAMD. The exclusion
criteria included combination with any retinal or choroidal
diseases in one or both eyes or other neovascularised macu-
lopathies, such as pathologic myopia, angioid streaks, idio-
pathic CNV, multifocal choroiditis, et al.
The control subjects were unrelated people aged ≥
50 years old without family histories of AMD. They all
underwent ocular examinations, including visual acuity,
slit-lamp biomicroscopy, direct ophthalmoscopy and 50Table 1 The clinical characteristics of the participants
Characteristics PCV nAMD
Number (n) 251 157
Gender (female/male) 84/167 56/101
Mean age ± SD years 65 ± 8.61 67 ± 9.21
Age ranges (years) 42-85 46-84
PCV: polypoidal choroidal vasculopathy.
nAMD: neovascular age-related macular degeneration.
*: PCV group compared with control group.
†: nAMD group compared with control group.degree fundus photography. Cases with any macular de-
generation or changes, such as drusen, pigment abnormal-
ities, or non-clear media preventing macular visualization,
were excluded from the study.SNP genotyping
Antecubital vein peripheral blood samples were obtained
from all of the participants and were placed in tubes con-
taining ethylene diamine tetraacetic acid. As previously
described [17], genomic DNA was isolated from periph-
eral blood samples using the Nucleospin_Blood XL kit
(Machery-Nagal GmbH﹠Co., KG Düren, Germany), and
it was stored at −20°C. Rs6982567 variants were geno-
typed using the SNaPshot System with an ABI 3730XL
genetic analyser (Applied Biosystems, Foster City, CA,
USA). The primer sequences were 5′- CATGAAATATC
ATCCACAGACAA-3′ (forward) and 5′- TCATTCAGT
ATATGCTCCTTAG-3′ (reverse), and the extension pri-
mer was TTTTTTTTTTTTTTGATTTTTTCCACATGTA
GTCCT. Genemapper software, version 4.1(Applied Biosystems,
Foster City, CA, USA), was used to determine the genotypes
of the SNP.Statistics
Statistical analysis was performed using SPSS software,
version 13.0 (SPSS Inc., Chicago, IL, USA). Student’s un-
paired t-test and the chi-square test were used to assess
the differences in mean age and sex between the subjects
and controls. A p value < 0.05 was considered statistically
significant. The exact test included in the PLINK software
package, version 1.07, was used to test the deviations from
Hardy-Weinberg equilibrium [18]. The chi-square test in
PLINK was used to determine the allele frequencies of the
SNPs in the case subjects. To assume the genotypic addi-
tive model, dominant and recessive model, the logistic
option and model option in PLINK were used, respect-
ively. Bonferroni’s method was performed to correct the p
values in multiple comparisons, with a p value <0.0056
(0.05÷3÷3) considered to be statistically significant.
G*Power software, version 3.1.10, was used to evaluate
the post-hoc power [19].Control p value* p value†
204
80/124 0.204 0.488
69 ± 9.00 <0.001 0.097
50-87
Table 2 The association test for the minor allele
frequency of rs6982567
Status HWE MAF OR (95% CI) p value
Control 0.1016 0.2623
PCV 0.2555 0.2912 1.29(0.97-1.73) 0.0832
nAMD 0.5798 0.2548 0.91(0.65-1.28) 0.6029
PCV + nAMD 0.6167 0.2794 1.14(0.87-1.49) 0.3444
SNP: single nucleotide polymorphism.
PCV: polypoidal choroidal vasculopathy.
nAMD: neovascular age-related macular degeneration.
MAF: minor allele frequency.
HWE: p value of Hardy-Weinberg equilibrium test.
OR: odds ratio.
95% CI: 95% confidence interval.
Minor allele frequencies were calculated based on all study participants.
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A total of 612 participants were enrolled: 251 PCV pa-
tients, 157 nAMD patients and 204 control individuals.
Table 1 showed the clinical baseline characteristics. The
mean age of the PCV group (65 ± 8.61 years) was younger
than the control group, and the difference was significant
(p < 0.001). There were no significant differences in other
characteristics, such as sex among the three groups.
For the quality assurance of our samples, the genotyping
call rates were 100% for rs6958967 in both the patient and
control groups. The genotypes were determined using the
SNaPshot method successfully in all of the subjects. To
confirm the accuracy of the SNaPshot method, ran-
domly selected subjects (10% of all samples) were ana-
lysed by direct sequencing. The consensus rate in the
replicate samples (n = 61) was 100%. The results of
Hardy-Weinberg equilibrium (HWE) analysis showed no
significant deviation in rs6982567, as shown in Table 2.
The allele frequencies of rs6982567 were not significantly
associated with nAMD, PCV or PCV and nAMD com-
bined. The frequencies of the T allele were 29.12% forTable 3 The association test for the genotype of rs6982567
Genotype distribu
Group Genotype Case Control O
PCV CC 117 106
TC 110 89 1.
TT 24 9 2.4
nAMD CC 92 106
TC 53 89 0.
TT 12 9 1.
PCV + nAMD CC 209 106
TC 163 89 0.
TT 36 9 2.
SNP: single nucleotide polymorphism.
PCV: polypoidal choroidal vasculopathy.
nAMD: neovascular age-related macular degeneration.
OR: odds ratio; 95% CI: 95% confidence interval.PCV, 25.48% for nAMD, and 27.94% for PCV and nAMD
combined. The odds ratio (OR) for the risk allele T of
rs6982567 was 1.29 for PCV [95% confidence interval (CI),
0.97-1.73, p = 0.0832], 0.91 for nAMD (95% CI, 0.65-1.28,
p = 0.6029), and 1.14 for PCV and nAMD combined (95%
CI, 0.87-1.49, p = 0.3444).
The genotype association test of rs6982567 was sum-
marised in Table 3. Subjects with the TT genotype had a
2.42-fold times greater risk of PCV (95% CI, 1.07-5.43,
p = 0.0290) than subjects with the CC genotype. The vari-
ant was significantly associated with PCV under a reces-
sive model (OR, 2.29; 95% CI, 1.04-5.05; p = 0.0351).
However, after Bonferroni correction, the p value was
insignificant (p > 0.0056). The genotype distributions and
additive, dominant and recessive models were not signifi-
cantly associated with nAMD (all p values >0.05). Combin-
ing PCV with nAMD as a group, the genotype distributions
and additive and dominant models also showed no signifi-
cant differences (all p values >0.05). Although there was a
marginal association under a recessive model in the PCV
and nAMD combined group (p = 0.0487), it could not with-
stand the Bonferroni correction (p > 0.0056).
The present sample size showed >80% power to detect
significant association for power calculations (α < 0.017),
and the effect size of 0.2 corresponded to a weak-to-
moderate gene effect. When comparing patients to
controls, the allele powers for PCV and nAMD were
97.00% and 92.12%, respectively, and the genotype
powers for PCV and nAMD were 94.01% and 86.42%,
respectively.
Discussion
Both PCV and nAMD are most common causes of irre-
versible visual impairment in older people worldwide. The
exact pathogenesis remains unknown, and the complex
genetic backgrounds remain under exploration. In thistion Genotype
R (95%CI) p value Model OR (95%CI) p value
reference Additive 1.31(0.97-1.78) 0.0747
12(0.76-1.64) 0.5657 Dominant 1.24(0.86-1.79) 0.2560
2(1.07-5.43) 0.0290 Recessive 2.29(1.04-5.05) 0.0351
reference Additive 0.91(0.65-1.29) 0.5961
69(0.44-1.07) 0.0931 Dominant 0.76(0.50-1.16) 0.2088
54(0.62-3.81) 0.3510 Recessive 1.79(0.74-4.37) 0.1936
reference Additive 1.14(0.87-1.50)0.3390
93(0.66-1.32) 0.6801 Dominant 1.03(0.74-1.44) 0.8625
03(0.94-4.37) 0.0660 Recessive 2.10(0.99-4.44) 0.0487
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typing in Chinese PCV and nAMD patients. The results
suggested that a weak association might exist between
rs6982567 near GDF6 and PCV. The marginal associ-
ation under a recessive model in the PCV and nAMD
combined group might be attributed to that between
this SNP and the PCV group.
GDF6 belongs to the largest gene group within the TGF
superfamily [20], which plays an important role in vascular
angiogenesis and remodelling [21,22]. GDF6 has functions
in eye and retinal development [23]. Sequence alterna-
tions in GDF6, such as amino acid substitutions, have
been identified in some patients with ocular anomalies
(microphthalmia, anophthalmia, coloboma) and vertebral
segmentation anomalies [15,24-26]. GDF6 also participates
in tissue healing and remodelling [23,27]. Wolfman N M
found that, in rats, three members of TGF-β family, GDFs
5, 6, and 7, could induce dense connective tissue forma-
tion rich in collagen type I when implanted ectopically or
intramuscularly [28]. In vitro, the GDF6 gene plays a po-
tential role in tendon matrix modelling and remodelling
[29,30].
Bruch’s membrane is the innermost layer of the choroid
and is rich in elastin and collagen. Typical findings of PCV
on ICGA include an abnormal choroidal vascular network
surrounded by characteristic polyp-like dilations at the
border [31]. Notable sclerotic changes in PCV lesions
and an elastic layer within the walls in polypoidal vessel
disruption have been found in histopathologic studies
[32,33]. A mouse model of PCV demonstrated severe deg-
radation of the tunica media of choroidal vessel walls and
elastic laminae [34]. Our previous study had found that
circulating gelatinase levels were elevated in PCV patients
but not in nAMD patients, providing evidence of a
role of extracellular matrix metabolism in the patho-
genesis of PCV [35]. Considering GDF6’s role in ret-
inal development and tendon tissue function, mutations
of GDF6 could result in dysfunction of vascular and
supporting tissues, thus participating in the pathogenesis
of PCV.
A previous study in Caucasians showed that the
rs6982567 variant was associated with AMD [16]. There
were two primary reasons for the inconsistency. First, the
inclusion criteria were not the same. In the Caucasian
study, the patients were classified according to the Age-
Related Eye Disease Study classification, which included
the geographic atrophy and did not specify the diagno-
sis of PCV. In our study, ICGA was used to distinguish
PCV from AMD. Geographic atrophy was excluded from
our study. We only included neovascular AMD patients.
For this reason, the types of patients were not exactly
the same. Second, the study populations came from dif-
ferent ethnic group. The same SNP might have different
distributions in different populations. The serpin peptidaseinhibitor, clade G, member 1, (SERPING1) gene was re-
ported to be associated with Caucasian populations [36],
but the results were negative in Han Chinese and Japanese
populations [17,37]. In the HapMap project, the allele fre-
quencies of rs6982567 were 0.168 in Utah residents with
Northern and Western European ancestry, 0.279 in Han
Chinese people and 0.218 in Japanese people, exhibiting
differences across ethnicities. These differences could con-
stitute another explanation for the different outcomes.
There were also some limitations of our study. First, we
conducted it in a relatively small sample, so we could not
fully identify the associations between rs6982567 and PCV.
Second, we only investigated a single SNP near the GDF6
gene in this study. So far, other SNPs in GDF6 locus
and linkage disequilibrium (LD) analysis with this gene
have yet not been completely investigated. Therefore, a
complete survey of the whole target SNP in LD with the
GDF6 gene with a larger sample size would be needed.
Conclusions
In conclusion, we investigated the associations of SNP
rs6982567 with PCV, nAMD in a Han Chinese population.
There was a marginal association between rs6982567 and
PCV under a recessive model. Expanding the sample size
and exploring the whole target SNPs in or near GDF6
gene are needed in future studies.
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